Amanta Healthcare Limited has informed the Exchange regarding Board meeting held on September 26, 2025.
AMANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amanta Healthcare's board, at its September 26, 2025 meeting, approved unaudited financial results for Q1 FY26 (quarter ended June 30, 2025) along with an unmodified Limited Review Report from Price Waterhouse Chartered Accountants LLP. The company swung to a profit after tax of Rs. 350.72 lakhs compared with a loss of Rs. 36.19 lakhs in Q1 FY25, while revenue from operations stood at Rs. 6,530.71 lakhs versus Rs. 6,809.65 lakhs in the same quarter last year. EPS improved to Rs. 1.22 from a loss of Rs. 0.13, and profit before tax rose to Rs. 492.65 lakhs. This is the first quarterly filing since the company listed on NSE and BSE on September 9, 2025, following its IPO of 1 crore fresh equity shares at Rs. 126 per share. Separately, the board approved redemption of 1 crore unlisted 14% Non-Convertible Cumulative Participating Redeemable Preference Shares at Rs. 11.742 per share, aggregating Rs. 11.74 crores, payable from company profits.
The year-on-year swing to profitability is a positive signal for the newly-listed stock, though revenue dipped slightly and the EPS base remains modest. The Rs. 11.74 crore preference share redemption reduces future dividend obligations but will use part of the company's distributable profits.